Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India.

Nirmalkumar Choraria Savita Rangarajan M Joseph JohnShashikant AptePritam GuptaSeema PaiRohit ChandShyam ParvatiniG S H RamakanthJeremy RuponAmit ChhabraHitesh Bhaskarrao MuleyDamien Simoneau

Published in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion (2022)

Nonacog alfa was safe and effective for the prevention of hemorrhagic episodes in Indian males with congenital, severe hemophilia B. No participants developed FIX inhibitors, and no new safety signals were reported.

Keyphrases

early onset
replacement therapy
drug induced
smoking cessation